Sources | Names Used |
---|---|
CTRPv2 | decitabine:carboplatin (1:1 mol/mol) |
PharmacoGx | decitabine:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-13 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-13 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-12 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
mRNA | ELF1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-12 |
mRNA | CTD-2369P2.12 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-12 |
mRNA | SCAF4 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
mRNA | CDT1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |